Randomized phase II trial of the anti-angiogenic potential of doxorubicin and docetaxel; primary chemotherapy as Biomarker Discovery Laboratory
Titel:
Randomized phase II trial of the anti-angiogenic potential of doxorubicin and docetaxel; primary chemotherapy as Biomarker Discovery Laboratory
Auteur:
Miller, Kathy D. Soule, Sharon E. Calley, Cynthia Emerson, Robert E. Hutchins, Gary D. Kopecky, Kenyon Badve, Sunil Storniolo, AnnaMaria Goulet, Robert Sledge, George W.